Participate in Research

Browse Clinical Trials
MuReva for Head and Neck Cancer
Protocol: SITE00000012
Full Title
Photobiomodulation Therapy Using the MuReva Phototherapy System to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Patients with Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy
Description
This study enrolls adults with head and neck cancer. The purpose of the study is to learn if a light device used in the mouth during chemotherapy and radiation can help prevent oral mucositis.

You will use a mouthguard style device for 6-8 weeks. You will be randomized, like pulling a number from a hat, to use the study device or a sham device, which does not deliver any therapy. The study device is a mouthguard that will deliver 2.5 minutes of phototherapy to the mouth before each radiation appointment Patients will be also complete questionnaires and oral exams during the study.
Compensation: No
Eligibility
Diagnosed with cancer (pathologically confirmed squamous cell carcinoma) of the oral cavity, oropharynx, tonsil or base of tongue.
Scheduled to have a continuous course of Intensity-Modulated Radiation Therapy (IMRT) over an estimated 6 to 8 weeks.
Age Group: Adults
Principal Investigator: JENNIFER FRUSTINO
ClinicalTrials.gov: Open Study
Contact(s)
JAMES ZEMER
jameszem@buffalo.edu
+1 716-645-2521

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login